Home/Filings/4/0000914190-10-000751
4//SEC Filing

CARLSON CRAIG W 4

Accession 0000914190-10-000751

CIK 0001140028other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:08 PM ET

Size

9.2 KB

Accession

0000914190-10-000751

Insider Transaction Report

Form 4
Period: 2010-12-21
CARLSON CRAIG W
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2010-12-21+705,000705,000 total
    Exercise: $0.49Exp: 2020-12-21Common Stock (705,000 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $0.92Exp: 2020-06-07Common Stock (62,500 underlying)
    62,500
  • Stock Option (right to buy)

    Exercise: $0.76Exp: 2020-03-01Common Stock (87,500 underlying)
    87,500
Footnotes (4)
  • [F1]On 9/10/10, the Company completed a one-for-four reverse stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to 9/10/10 have been adjusted to reflect the one-for-four reverse stock split.
  • [F2]One-third of the shares vest on 3/1/11 and the remaining two-thirds vest in 24 equal monthly installments thereafter.
  • [F3]One-third of the shares vest on 6/7/11 and the remaining two-thirds vest in 24 equal monthly installments thereafter.
  • [F4]Shares vest in 48 equal monthly installments beginning 1/21/11.

Issuer

Talon Therapeutics, Inc.

CIK 0001140028

Entity typeother

Related Parties

1
  • filerCIK 0001231319

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:08 PM ET
Size
9.2 KB